REATA PHARMACEUTICALS INC 3 SEC Filings

Filed On	Filing
07 Aug 2023	Form 3: Biogen Inc., See footnotes Holds 0 shares of Class A common stock
14 Jun 2023	Form 3: Patni Rajiv, EVP, Chief R&D Officer No securities owned
11 Jul 2022	Form 3: Ryder Steven, Director No securities owned
07 Feb 2022	Form 3: Loewen Andrea, SVP, Global Regulatory Affairs Holds 32,856 shares of Class A common stock
07 Feb 2022	Form 3: Khan Samina, SVP, Chief Medical Officer Holds 35,149 shares of Class A common stock
15 Nov 2021	Form 3: Anand Bhaskar, VP, Chief Accounting Officer Holds 4,000 shares of Class A common stock
15 Apr 2021	Form 3: Oliger Christy J., Director No securities owned
15 Apr 2021	Form 3: Ruff Shamim, Director No securities owned
04 Aug 2020	Form 3: Edwards Martin, Director No securities owned
29 Aug 2019	Form 3: Soni Manmeet Singh, Chief Financial Officer No securities owned
14 Nov 2018	Form 3: Evelyn Potter Rose Survivor's Trust, 10% owner Holds 879,281 shares of Class A common stock
02 Mar 2017	Form 3: McClellan William D. Jr., Director No securities owned
31 Oct 2016	Form 3: Bir Dawn Carter, VP, Chief Commercial Officer
27 Sep 2016	Form 3: AbbVie Inc., 10% owner Holds 135,232 shares of Class A Common Stock
13 Jun 2016	Form 3: Stapleton Pharma Llc, 10% owner and 1 other Holds 452,864 shares of Class A common stock
02 Jun 2016	Form 3: Puffin Partners, L.p., 10% owner and 3 others Holds 957,000 shares of Class A common stock
25 May 2016	Form 3: Cpmg Inc, Director
25 May 2016	Form 3: McGaughy R Kent Jr, Director
25 May 2016	Form 3: Traweek James W Jr, 10% owner
25 May 2016	Form 3: Novo A/S, 10% owner

Comments